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Abstract
Background:  The determination of virus-specific immunoglobulin G (IgG) antibodies in
cerebrospinal fluid (CSF) is useful for the diagnosis of virus associated diseases of the central
nervous system (CNS) and for the detection of a polyspecific intrathecal immune response in
patients with multiple sclerosis. Quantification of virus-specific IgG in the CSF is frequently
performed by calculation of a virus-specific antibody index (AI). Determination of the AI is a
demanding and labour-intensive technique and therefore automation is desirable. We evaluated the
precision and the diagnostic value of a fully automated enzyme immunoassay for the detection of
virus-specific IgG in serum and CSF using the analyser BEP2000 (Dade Behring).
Methods:  The AI for measles, rubella, varicella-zoster, and herpes simplex virus IgG was
determined from pairs of serum and CSF samples of patients with viral CNS infections, multiple
sclerosis and of control patients. CSF and serum samples were tested simultaneously with
reference to a standard curve. Starting dilutions were 1:6 and 1:36 for CSF and 1:1386 and 1:8316
for serum samples.
Results: The interassay coefficient of variation was below 10% for all parameters tested. There
was good agreement between AIs obtained with the BEP2000 and AIs derived from the semi-
automated reference method.
Conclusion: Determination of virus-specific IgG in serum-CSF-pairs for calculation of AI has been
successfully automated on the BEP2000. Current limitations of the assay layout imposed by the
analyser software should be solved in future versions to offer more convenience in comparison to
manual or semi-automated methods.
Background
The determination of virus-specific immunoglobulin G
(IgG) antibodies in cerebrospinal fluid (CSF) is an impor-
tant tool for the diagnosis of virus-associated diseases of
the central nervous system (CNS) and for the detection of
a polyspecific intrathecal immune response in patients
with multiple sclerosis (MS) [1,2]. Quantification of
virus-specific IgG in the CSF is frequently performed by
calculation of a virus-specific antibody index (AI) [3]. The
AI is the ratio of the CSF/serum quotient of virus-specific
IgG (Qspec) and of the CSF/serum quotient of total IgG
(QIgG), i. e. AI = Qspec/QIgG. The replacement of QIgG by
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Qlim has been proposed as a correction in cases of an
intrathecal IgG synthesis [3]. Qlim represents the upper
limit of the QIgG under the assumption that the IgG frac-
tion in the CSF originates only from blood. Qlim can be
calculated for an individual patient from the CSF/serum
quotient of albumin (QAlb) [4].
The determination of virus-specific antibodies is usually
performed using enzyme immunoassays. In order to
achieve a high precision, it is advisable to analyse CSF and
serum simultaneously with reference to a standard curve
[3]. Because the IgG content of CSF samples is usually
low, modifications of standard serum enzyme immu-
noassays are necessary to increase the sensitivity of the
detection of virus-specific antibodies. Possible modifica-
tions include increased incubation times and conjugate
concentrations [3,5]. With respect to the working dilu-
tions of serum and CSF, several aspects have to be consid-
ered. Highly concentrated CSF samples may lead to
unspecific matrix effects. On the other hand, dilution of
CSF samples will decrease the sensitivity of antibody
detection. The ratio of the serum and CSF working dilu-
tions should resemble the concentration gradient of IgG
between serum and CSF, which is approximately 200:1 for
healthy adults [3].
Overall, AI determination is a demanding and labour-
intensive technique and automation is desirable. There-
fore, we evaluated the precision and the diagnostic value
of a fully automated enzyme immunoassay for the detec-
tion of virus-specific IgG in serum and CSF using the ana-
lyser BEP2000 (Dade Behring).
Methods
Samples
The serum and CSF samples used in this study had been
sent to the virology laboratory at the University of Würz-
burg for routine testing of intrathecal synthesis for mea-
sles, rubella, varicella-zoster (VZV), and herpes simplex
virus (HSV) IgG. Samples of the following groups were
used in this study: psychiatric patients with normal CSF
findings (n = 29) who were tested for exclusion of inflam-
matory CNS disease; patients with a diagnosis of subacute
sclerosing panencephalitis (SSPE; n = 9), VZV meningitis
or encephalitis (n = 12), HSV encephalitis (n = 10), and
MS (n = 22).
The requested AI determination was performed routinely
in a semi-automated fashion after arrival of the samples in
the virology laboratory. Remaining material was stored at
-20°C for a mean period of 3 years (range 0 – 10 years).
For evaluation of the novel fully automated AI determina-
tion method, the stored aliquots were tested and the AI
values of the routine determinations were compared with
results obtained during the evaluation study. The study
was carried out in compliance with the Helsinki declara-
tion and was approved by the ethics committee of the
medical faculty at the University of Würzburg.
Semi-automated antibody index determination with the 
BEP III
Antibody index determination for IgG antibodies against
measles, rubella, VZV, and HSV was originally performed
with a semi-automated method as described previously
[6]. Enzyme immunoassay reagents contained in Dade
Behring Enzygnost IgG test kits (Dade Behring, Marburg,
Germany) were used for this purpose. All dilution and
pipetting steps of the standards and samples were per-
formed manually. The microtiter plates (MTP) were proc-
essed using a Behring Elisa Processor III (Dade Behring).
One of two pipetting schemes was used for the routine AI
determination (Figure 1). Either an 8-point-standard
curve with 1:2 dilution steps, or a 4-point-standard curve
with 1:4 dilution steps was pipetted on the first strip of
each microtiter plate. Commercial plasma pools such as
Standard Human Plasma (SHP, Dade Behring), which
serve as reference material in clinical chemistry, were used
for the standard dilutions. The starting dilution of each
standard curve, which varied according to the content of
virus-specific IgG, was assigned a value of 100 arbitrary
units (AU). Originally, serum and CSF samples were
tested in two dilutions each, namely 1:1386 and 1:8316
for serum, and 1:6 and 1:36 for CSF, respectively (Figure
1a). Later, serum and CSF were tested only in one dilution
each (Figure 1b). Where appropriate, higher dilutions in
steps of 1:6 were performed. In order to increase the sen-
sitivity of the IgG detection of the enzyme immunoassay
compared to the intended use of the Enzygnost test kits,
some modifications of the assay conditions were made.
These included a serum incubation time of 180 min
instead of 60 min, a conjugate dilution of 1:31 instead of
1:51, and a conjugate incubation time of 90 min instead
of 60 min. The washing, substrate and stop solution steps
and the photometer reading were performed according to
the instructions of the Enzygnost test kits. AUs of serum
and CSF samples were calculated with reference to the
standard curve included on each MTP. Subsequently, the
Qspec  was calculated according to the formula
. The AI was determined
as Qspec/QIgG when QIgG < Qlim or as Qspec/Qlim when QIgG
> Qlim as suggested by Reiber et al. [3]. Values of AI > 1.4
are indicative of an intrathecal synthesis of virus-specific
IgG.
Automated antibody index determination with the 
BEP2000
The fully automated AI determination was performed
with the BEP2000 (Dade Behring), a walk-away enzyme
immunoassay analyser with a pipetting device for dispos-
able tips. In contrast to the BEP III, the BEP2000 allows
Q
AU *dilution
AU *dilution
spec
CSF CSF
serum serum
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automation of the dilution and pipetting steps of the
standard curves and of the serum and CSF samples. The
pipetting scheme and the enzyme immunoassay parame-
ters were similar to the semi-automated method with
some modifications as described below. Reagents of the
Dade Behring Enzygnost IgG test kits were used for the
enzyme immunoassays and Standard Human Plasma
(Dade Behring) was used as standard material. The initial
evaluations were performed with an 8-point-standard
curve and two dilutions each of serum and CSF (Figure
1a). In order to optimise the intraassay variation and to
obtain similar absolute optical density values with the
BEP2000 compared to the semi-automated method with
the BEP III, the conjugate incubation time was reduced
from 90 min to 60 min and the dispensed volume of the
substrate and stopping solution was reduced from 100 µl
to 75 µl.
After successful implementation of the 8-point-standard
curve method on the BEP2000, the method was adapted
to the 4-point-standard curve method with one dilution
each for serum and CSF (Figure 1b) in order to minimise
reagent costs. For both the 8-point- and 4-point-standard
curve method, the dilutions of serum and CSF samples are
fixed, which meant that CSF and serum samples were pre-
diluted manually where necessary.
Calculation of intraassay and interassay variation
To determine the intraassay and interassay variation of the
automated AI determination method, an artificial serum-
CSF-pair was used as run control. It was produced from a
plasma pool containing IgG against measles virus, rubella
virus, VZV and HSV. Undiluted plasma pool was aliq-
uoted and stored at -20°C to serve as "serum run control"
(SRC). For the artificial CSF sample, the plasma pool was
manually prediluted 1:231 in sample buffer, aliquoted
and also stored at -20°C (CSF run control, CRC). During
the AI determination, the CRC is treated as CSF sample
and therefore diluted 1:6. Taking into consideration the
manual predilution of 1:231, the final dilution with
respect to the undiluted plasma pool is 1:1386. This cor-
responds to the test dilution of serum samples in the AI
enzyme immunoassay. Thus, the optical density and the
AU values of SRC and CRC should theoretically be equal.
The ratio of AUCRC/AUSRC can serve as a quality control
parameter for the AI determination method and is used
for calculation of intraassay and interassay coefficients of
variation. In order to validate the use of the pre-diluted
serum pool as a CSF surrogate marker, we compared
intraassay variation of a serum-CSF-pair that was available
in large enough quantity with the artificial serum-CSF-
pair. The results of the coefficients of variation of both
sample pairs were in a similar range.
Results
In order to obtain an impression of the performance of
the automated AI determination on the BEP2000, the
dilution linearity of the standard curves and the intraassay
and interassay coefficients of variation were tested in ini-
tial experiments. Representative examples of 8-point-dilu-
tions standard curves are shown in Figure 2a. The dilution
linearity was good and the linear range of the curves
extended from 0.100 to at least 2.500 optical density.
To determine the imprecision of the method, the coeffi-
cient of variation of the ratio AUCRC/AUSRC was calculated
for each virus by testing a run control, which represented
an artificial serum-CSF-pair and was available in large
quantity to allow repeated testing (Table 1). The inte-
rassay coefficient of variation was around 5 – 9% for all
parameters tested.
To evaluate the clinical usefulness of the fully automated
method, archived serum-CSF-pairs that had originally
Pipetting schemes of the AI determination methods Figure 1
Pipetting schemes of the AI determination methods. 
AI determinations were performed with two microtiter plate 
layouts. Every second strip of the microtiter plates is coated 
with control antigen (CoAg). Standard positions (St.) with 
the corresponding arbitrary units (AU) are presented in bold 
type. Shading indicates pairs of serum and CSF samples. (A) 
8-point-standard curve and two dilutions each for serum and 
CSF. (B) 4-point-standard-curve and one dilution each for 
serum and CSF.
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been tested for AI values in a semi-automated fashion
were retested with the BEP2000. The results of normal
controls are shown in Table 2. Results obtained with the
BEP2000 and AI values derived from the semi-automated
reference method were in good agreement. The standard
deviations of the BEP2000 results were lower than the
standard deviations of the semi-automated method. AI
results of the different samples groups (MS, VZV and HSV
infection, SSPE, normal controls) were highly correlated
(Table 3). Detailed results of the MS group are presented
in Table 4. Overall, there was good qualitative (cut-off
1.4) and quantitative agreement between both methods.
For eight of the 88 AI values obtained with each method,
there were qualitative differences between the semi-auto-
mated method and the 8-point-standard curve method on
the BEP2000 (underlined in Table 4). However, the dis-
crepant values varied only in a narrow range, and none of
the samples was found as falsely normal with either
method when all four viruses tested were considered.
Because of the good precision and reproducibility of the
results obtained with the 8-point-standard curve pipetting
scheme (Figure 1a), the automated method was modified
in order to minimise reagent costs. The standard curve was
reduced from 8 points to 4 points, and serum and CSF
were tested in only one dilution each (Figure 1b). Repre-
sentative standard curves and coefficients of variation
obtained with the modified method are shown in Figure
2b and Table 1. The results were comparable to the 8-
point-standard curve pipetting scheme. Finally, clinical
samples were also tested with the 4-point-standard curve
pipetting scheme. For the normal controls, there was a
good agreement between the results obtained with the
semi-automated method, the 8-point and the 4-point-
standard curve method (Table 2). AI results of the differ-
ent samples groups were highly correlated between the
semi-automated method and the 4-point-standard curve
method on the BEP2000 as well as between the 4-point-
and 8-point-standard curve method on the BEP2000
(Table 3). For four of 76 AI values obtained with the 4-
point-standard curve method in the MS sample group,
there were qualitative discrepancies compared to the other
two methods. However, at least one AI was elevated in all
of the MS samples and none of them was found to be
entirely normal (Table 4).
Discussion
Detection of intrathecal synthesis of virus-specific anti-
bodies is an important tool in the diagnosis of inflamma-
tory diseases of the CNS. Various methods have been
proposed for this purpose [2,6,7]. The required specifica-
tions of the methods are partially dependent on their clin-
ical use. Sensitive detection of a polyspecific antiviral
immune response in patients with chronic inflammatory
CNS disease, such as MS, can be achieved by AI determi-
nation and is especially demanding with respect to assay
precision [1,8]. While automated assays have become an
integral part of serological laboratories in recent years,
antibody index determination in serum-CSF-pairs has
been difficult to automate so far because of its complexity.
In this study, we have successfully advanced an estab-
lished semi-automated method for AI determination to
full automation on the enzyme immunoassay analyser
BEP2000.
In order to obtain a high precision of the antibody index
values, the optical densities of serum and CSF in the
enzyme immunoassay should fall in a similar range.
Therefore, working dilutions of serum and CSF were cho-
Standard curves obtained with the BEP2000 Figure 2
Standard curves obtained with the BEP2000. Log-log 
diagrams of representative 8-point-standard curves (A) and 
4-point-standard curves (B) obtained with the BEP2000 for 
measles, rubella, VZV, and HSV. Each curve represents a sep-
arate run. Arbitrary units assigned to the standard dilutions 
are shown on the x-axis. Optical density values (OD) are 
shown on the y-axis.
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sen as to resemble the concentration gradient of IgG
between serum and CSF, which resulted in rather high
serum dilutions. As a consequence, six aspiration and
three dispensing steps were necessary to obtain the serum
working dilution 1:1386, and two pipetting steps were
required for the CSF dilution (1:6). Because the inaccura-
cies of each pipetting step add up to the sum error of Qspec,
a high precision of the pipetting process is required. This
aim has been achieved by the automated method as dem-
onstrated by the low coefficient of variation of the run
controls. In our experience, the precision of the BEP2000
tends to be higher than the precision that can be achieved
by manual pipetting in a routine diagnostic setting with
rotating personnel and time constraints.
This observation is also supported by the correlation coef-
ficients for the measles virus AI values (Table 3). Correla-
tion between the values obtained with the automated 4-
point- and 8-point-standard curve methods was higher
than the correlation between either automated method
and the semi-automated method. This is probably attrib-
uted to the inclusion of samples from SSPE patients in the
study. These samples are characterised by extremely high
titres of measles virus IgG. As a result, serum and CSF sam-
ples have to be tested in very high dilutions in order to
obtain optical density values in the linear range of the
enzyme immunoassay. Common working dilutions for
these samples are 1:299376 for serum (i. e. 8316 × 6 × 6)
and 1:7776 for CSF (i. e. 36 × 6 × 6 × 6). Due to these addi-
tional dilution steps, the imprecision of the measles virus
AI determinations of the SSPE samples derived from rou-
tine testing with the semi-automated method is probably
higher than the imprecision of the automated determina-
tions performed within this study.
An additional explanation for discrepancies between AI
values obtained with different methods, apart from
imprecision of pipetting and enzyme immunoassay
processing, may be lot-to-lot variation of the antigen com-
position of the MTP. In fact, we have observed some qual-
itative AI discrepancies when MS samples were tested in
parallel with five different lots of measles MTP (data not
shown). In contrast to a polyclonal immune response
directed against a broad spectrum of epitopes, effects of
antigen variation may become apparent more easily in
cases of an oligoclonal immune response, which is
directed against only a few antigenic sites.
The 8-point-standard curve assay layout with two dilu-
tions for each serum and each CSF sample, which was
originally employed, was useful for evaluation purposes
but is very reagent consuming. The assay was made more
Table 2: Antibody index results of normal controls
semi-automated method 8-point-standard curve BEP2000 4-point-standard curve BEP2000
Measles Rubella VZV HSV Measles Rubella VZV HSV Measles Rubella VZV HSV
Mean 0.81 0.93 0.96 1.06 0.89 0.91 0.96 1.03 0.83 0.91 0.94 1.02
Standard deviation 0.17 0.12 0.18 0.20 0.13 0.11 0.13 0.14 0.15 0.13 0.15 0.18
Minimum 0.50 0.70 0.70 0.80 0.67 0.68 0.72 0.73 0.57 0.70 0.75 0.71
Maximum 1.30 1.10 1.30 1.30 1.16 1.10 1.18 1.30 1.13 1.17 1.42 1.34
Table 1: Intraassay and interassay variation of the ratio AUCRC/AUSRC 
1
semi-automated method 8-point-standard curve BEP2000 4-point-standard curve BEP2000
Measles Rubella VZV HSV Measles Rubella VZV HSV Measles Rubella VZV HSV
Intraassay
n 1 01 0 1 0 1 0 1 01 0 1 0 1 0
Mean n. d.2 n. d. n. d. n. d. 0.95 0.92 0.95 0.91 0.89 0.89 0.91 0.91
Standard deviation n. d. n. d. n. d. n. d. 0.04 0.06 0.04 0.05 0.03 0.01 0.06 0.03
Coefficient of variation n. d. n. d. n. d. n. d. 4.5% 6.9% 4.5% 5.1% 3.2% 1.6% 6.8% 3.1%
Interassay
n 2 01 9 2 2 2 4 1 01 0 1 1 1 1 2 01 9 2 3 1 9
Mean 1.10 1.06 1.04 1.09 0.99 0.97 0.96 0.96 1.05 1.07 1.14 1.06
Standard deviation 0.15 0.11 0.09 0.13 0.05 0.06 0.08 0.07 0.10 0.04 0.07 0.08
Coefficient of variation 14.0% 10.3% 8.9% 12.2% 5.3% 6.2% 8.6% 6.9% 9.6% 4.1% 6.3% 7.3%
1CRC and SRC represent an artificial serum-CSF-pair available in sufficient quantity to be repeatedly tested. The theoretical value of AUCRC/AUSRC 
is 1. For further details, see method.
2 n. d. – not determinedBMC Neurology 2007, 7:12 http://www.biomedcentral.com/1471-2377/7/12
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cost-effective by using only one instead of two sample
dilutions and by using a 4-point standard curve instead of
an 8-point standard curve. While only 10 serum-CSF-pairs
can be tested on one MTP with the 8-point-standard curve
layout (the Enzygnost assays include control antigen
strips), 22 pairs can be tested with the 4-point-standard
curve and the single dilution layout. Obviously, the reduc-
tions of sample dilutions will lead to a higher retest rate
because optical density values of the starting dilutions
may fall in the saturation range of the standard curve.
Advantages and disadvantages of the different layouts
have to be balanced by each laboratory depending on the
individual needs.
A limitation of both the semi-automated and the auto-
mated method are the long serum and conjugate incuba-
tion times. The extension of these incubation times
compared to the standard IgG assay was originally imple-
mented in analogy to the method described by Reiber and
Lange [3]. The duration of processing one plate on the
BEP2000 from start to finish is approximately 6 hours.
Because the BEP2000 has only four MTP incubators, it can
handle only four plates at a time. Thus, the throughput is
40 results per working day with the 8-point standard curve
method and 88 results per working day with the 4-point
standard curve method. Since the BEP2000 is a walk-away
analyser, it may be possible to double the throughput by
reloading the machine at the end of the working day.
Obviously, shortening the incubation times would further
increase the throughput. Assay modifications to this end
are currently ongoing.
Table 4: Antibody index results of MS patients. AI > 1.4 is indicative of intrathecal synthesis of virus-specific IgG. Qualitative differences 
between the semi-automated method and the 8-point-standard curve method on the BEP2000 are underlined. Qualitative differences 
between the 4-point-standard curve method (BEP2000) and the other two methods are shown in bold face and italics
semi-automated method 8-point-standard curve BEP2000 4-point-standard curve BEP2000
sample IgG index1 Measles Rubella VZV HSV Measles Rubella VZV HSV Measles Rubella VZV HSV
1 1.37 2.7 neg.2 9.5 neg. 3.7 neg. 11.0 neg. 4.0 neg. 11.4 neg.
2 1.31 1.7 1.6 17.5 0.4 1.6 1.8 15.2 0.6 1.4 1.9 20.3 1.2
3 1.08 3.1 0.7 1.6 0.5 2.9 0.9 1.4 0.7 1.9 0.8 1.2 0.7
4 0.87 5.9 0.7 11.9 1.9 7.7 0.8 10.5 2.0 1.3 0.7 10.3 1.1
5 1.18 42.2 6.9 1.8 3.0 24.7 9.7 3.1 2.4 22.1 11.6 2.7 2.2
6 1.36 5.9 14.3 9.4 neg. 6.1 14.5 9.3 neg. 4.9 12.6 8.8 neg.
7 1.88 43.4 0.8 2.2 neg. 35.8 1.6 3.5 neg. 29.4 1.3 2.0 neg.
8 1.15 2.6 2.9 1.0 0.5 3.2 2.5 1.0 0.7 4.1 2.6 0.8 0.5
9 1.08 2.8 1.2 0.6 0.6 5.9 3.9 1.7 0.7 n. d. 3 n. d. n. d. n. d.
10 0.73 2.5 1.6 1.5 2.1 2.0 1.4 0.8 1.2 2.6 1.2 0.8 0.9
11 3.19 11.8 3.7 1.6 neg. 5.0 3.1 1.6 neg. 3.7 2.6 1.2 neg.
12 0.99 6.3 3.4 7.6 0.7 9.0 2.8 2.9 0.6 n. d. n. d. n. d. n. d.
13 0.98 1.1 2.2 2.3 1.2 1.1 5.8 1.4 0.9 n. d. n. d. n. d. n. d.
14 1.78 1.3 9.5 1.9 neg. 1.2 12.0 3.3 neg. 1.4 10.4 3.7 neg.
15 2.20 4.4 1.8 4.1 neg. 3.5 1.8 3.4 neg. 3.5 1.6 2.9 neg.
16 2.27 3.0 2.6 n. a.4 2.1 4.5 4.2 3.4 3.3 3.2 3.2 3.0 1.6
17 1.21 7.0 4.5 0.9 0.4 5.3 4.0 1.0 0.7 8.4 5.8 0.9 0.6
18 4.23 10.1 44.7 10.7 1.0 8.8 37.4 10.4 0.9 9.1 41.7 10.5 1.0
19 2.78 12.3 11.0 17.5 0.9 7.1 11.4 19.1 1.0 7.7 13.6 19.3 1.0
20 2.04 5.7 3.8 1.9 2.6 8.6 5.8 2.2 1.6 8.9 5.2 2.1 1.9
21 2.65 2.1 4.2 3.4 7.1 2.3 3.0 5.3 5.8 1.9 1.8 3.6 5.7
22 0.98 11.4 1.5 2.5 1.2 5.3 1.9 2.4 1.2 6.4 1.9 2.3 1.0
1 IgG index = QIgG/QAlb
2 neg. – virus specific IgG below the detection limit; an AI could not be calculated
3 n. d. – not determined because of insufficient sample volume
4 n. a. – a VZV AI value from routine determinations with the semi-automated method was not available
Table 3: Correlation coefficients r for pairwise comparisons of the AI values obtained with different methods for patient samples (MS, 
HSV and VZV infection, SSPE) and normal controls
Method comparison Measles Rubella VZV HSV
semi-automated and BEP2000 (8-point-standard curve) 0.95 0.98 0.97 0.98
semi-automated and BEP2000 (4-point-standard curve) 0.94 0.99 0.97 0.98
BEP2000 (8-point and 4-point-standard curve) 0.99 0.99 0.96 0.99BMC Neurology 2007, 7:12 http://www.biomedcentral.com/1471-2377/7/12
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Because the CSF volume available for serology is often
limited, minimising the required sample volume is
important. In the assays described in this paper, 160 µl of
CSF are necessary for determination of antibody indices
for measles, rubella, VZV, and HSV. This volume includes
4 × 20 µl = 80 µl required for control antigen wells which
are part of the Dade Behring test kits. However, in our
experience reaction of CSF samples with control antigen
in IgG enzyme immunoassays is extremely rare. Therefore,
pipetting of the control antigen well has been omitted for
CSF samples in a modified semi-automated version of the
antibody index assay, which is currently under evaluation.
A shortcoming of the automated antibody index method
is the limited flexibility of the current version of the ana-
lyser software. The dilution steps are invariable and attrib-
uted to fixed positions of the assay layout. Thus, testing of
samples in higher dilutions, when the absolute antibody
titre exceeds the linear range of the standard curve,
requires manual predilution steps. Testing of samples in
lower dilutions is not possible at all. Furthermore, testing
of some samples in one dilution and others in two dilu-
tions on the same plate is not possible without manual
sample splitting and predilution. While the automated
method is well suited for initial testing of large numbers
of serum-CSF-pairs, its use is more laborious for the anti-
body-titre-adapted retesting of those samples, for which
an antibody index could not be calculated in the initial
testing.
The method described in this paper is an in-house
method and has not been officially validated by the man-
ufacturer. As a consequence, the reagents used for this
assay have not been validated for this purpose either.
Especially the quality of the MTPs, coated with viral anti-
gen, of the anti-human IgG conjugate, and of the plasma
pools used for the standard curves, will have a significant
influence on the optical density values of the samples and
the standard curves. Establishment of specifications for
the use of these reagents in CSF diagnosis, which take lot-
to-lot variations into account, is therefore recommended.
It is particularly important to define upper and lower lim-
its of the linear range of the standard curve, in order to
ensure reporting of correct antibody index results.
Conclusion
Determination of virus-specific IgG has been successfully
automated on the BEP2000. The interassay variation of
the AIs obtained with the BEP2000 was low and there was
a good agreement between the automated and the semi-
automated method. Automation may ultimately lead to a
better standardisation of CSF analysis. Necessary
improvements of the analyser software will hopefully
increase the flexibility of the automated method in the
future.
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